Vanishing bile duct syndrome in human immunodeficiency virus: Nevirapine hepatotoxicity revisited

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 26

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

395

HTML

3683

Figures (1-4)

606

Tables (1-1)

372

Sum=5056

Jul 14, 2010 (publication date) through Nov 21, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Jul 14, 2010; 16(26): 3335-3338
Published online Jul 14, 2010. doi: 10.3748/wjg.v16.i26.3335

Table 1 Drugs reported to cause chronic cholestasis and ductopenia

Antibiotics	Psychiatric drugs	Antiepileptic drugs	Oral hypoglycemics	Hormonal agents	Others
Ampicillin	Amitriptyline	Phenytoin	Carbutamide	Estradiol	Ibuprofen
Amoxicillin/clavulanic acid	Chlorpromazine	Carbamazepine	Tolbutamide	Methyltestosterone	Phenylbutazone
Amoxicillin/clavulanic acid	Haloperidol	Barbiturates	Glibenclamide	Norandrostenolone	Cyproheptadine
Clindamycin	Imipramine	Diazepam			Cimetidine
Trimethoprim/sulfamethoxazole	Prochlorperazine				Cromolyn sodium
Trimethoprim/sulfamethoxazole	Trifluperazine				Chlorothiazide
Flucloxacillin
Tetracyclines
Thiabendazole
Erythromycin
Troleandomycin

Citation: Kochar R, Nevah MI, Lukens FJ, Fallon MB, Machicao VI. Vanishing bile duct syndrome in human immunodeficiency virus: Nevirapine hepatotoxicity revisited. World J Gastroenterol 2010; 16(26): 3335-3338
URL: https://www.wjgnet.com/1007-9327/full/v16/i26/3335.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i26.3335